Trade names or approved names. Part III. Special cases. Drugs for rare diseases.
D003365:Costs and Cost Analysis; D004341:Drug Evaluation; D004353:Drug Evaluation, Preclinical; D004345:Drug Industry; D006527:Hepatolenticular Degeneration / Q000188:drug therapy; D006801:Humans; D010396:Penicillamine / Q000627:therapeutic use; D012106:Research
D010396:Penicillamine